Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Celgene
Alliance for Clinical Trials in Oncology
Spanish Breast Cancer Research Group
National Heart, Lung, and Blood Institute (NHLBI)
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute, Egypt
NYU Langone Health
Merck Sharp & Dohme LLC
University of Arizona
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Hoffmann-La Roche
Seattle Children's Hospital
University of California, San Diego
Dana-Farber Cancer Institute
Genentech, Inc.